Article

Circulating Metabolites Associated with Prothrombin Time and Activated Clotting Time in Children with Congenital Heart Disease: An Untargeted Metabolomics Study

2025-11-09

Abstract excerpt

<h4>Background</h4> Coagulation markers are used to guide clinical anticoagulation decisions. We aimed to identify circulating metabolites that are associated with coagulation markers in children with congenital heart disease (CHD). <h4>Methods</h4> Plasma samples were separated from whole blood under consistent conditions. Untargeted metabolomic data were measured in plasma from up to 203 young patients (age ra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f3d6427-44c9-5391-b75f-092a9e2a6983
DOI: 10.1101/2025.11.07.25339794

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating Metabolites Associated with Prothrombin Time and Activated Clotting Time in Children with Congenital Heart Disease: An Untargeted Metabolomics StudyDOI 10.1101/2025.11.07.25339794Read

Metabolomics: A New Tool in Our Understanding of Congenital Heart DiseaseSemantic proximity Read

Untargeted metabolomics analysis of differences in metabolite levels in congenital heart disease of varying severitySemantic proximity Read

The relationship of maternal gestational mass spectrometry-derived metabolites with offspring congenital heart disease: results from multivariable and Mendelian randomization analysesSemantic proximity Read

Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligenceSemantic proximity Read

Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels.Semantic proximity Read

The Interactions and Biological Pathways Among Metabolomics Products of Patients with Coronary Heart Disease Analyzed Using the Bioinformatics MethodsSemantic proximity Read

High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart Disease.Semantic proximity Read

Metabolomic prediction of fetal congenital heart defect in the first trimesterSemantic proximity Read

Congenital heart defects and maternal genetic, metabolic, and lifestyle factors.Semantic proximity Read

Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.Semantic proximity Read

Alterations of Plasma Metabolites Associated with Sickle Cell Trait.Semantic proximity Read

Noninvasive screening for congenital heart defects using a serum metabolomics approachSemantic proximity Read